While the above findings indicate that NF-κB regulates and interacts with many of the master transcription factors linked to mesenchymal differentiation in GBM, downstream of these master regulators a battery of structural and secreted proteins mediate the mesenchymal phenotype. The gene discussed is NFKB1; the disease is glioblastoma.